Compare 20/20 GeneSystems vs Chronix Biomedical
Customers evaluate the quality of 20/20 GeneSystems's products using the following success metrics.
Overview
20/20 GeneSystems is based in United States
20/20 GeneSystems is a company focused on modernizing clinical lab testing, primarily in the healthcare and biotechnology sectors. The company offers diagnostic tests that aid in the fight against cancer and COVID-19, utilizing machine learning and real-world data to provide comprehensive testing services. Their main offerings include a blood test that combines the results of multiple cancer biomarker tests to calculate a probability score for different types of cancers, and a range of COVID-19 testing services. It is based in Rockville, Maryland.
Chronix Biomedical is 24 yrs old and is based in United States.
Chronix Biomedical is a US-based molecular diagnostics company developing blood tests primarily for the screening and monitoring of cancer. Chronix offers supplemental screening evaluation tests based on copy number instability for breast and prostate cancer through its own certified laboratories in Gottingen, Germany. The prostate cancer test can discriminate between prostate cancer and other prostate conditions (such as benign prostatic hypertrophy and prostatitis) thereby avoiding invasive needle biopsies when unnecessary. These Chronix supplementary tests assist oncologists in making cancer diagnoses and can reduce costs to healthcare providers by preventing unnecessary procedures such as tissue biopsies. On February 4th, 2021, Chronix Biomedical was acquired by Oncocyte. Terms of the transaction were not disclosed.
Demo Video
Leadership
Jonathan Cohen (Founder, Chief Executive Officer, President)
William A Boeger (Founder)
Investors
Keiretsu Forum, Ping An Venture Capital
OncoCyte, PrairieGold Venture Partners
Product
Benefits
Products
Customers
Known Partners
Why They Buy
Information not available because 20/20 GeneSystems has not claimed their profile.
Work for 20/20 GeneSystems? Claim your profile by submitting an Analyst Briefing. By submitting you can
Work for 20/20 GeneSystems?
Claim your profile now.
Information not available because Chronix Biomedical has not claimed their profile.
Work for Chronix Biomedical? Claim your profile by submitting an Analyst Briefing. By submitting you can
Work for Chronix Biomedical?
Claim your profile now.
Expert Collections
Digital Health
10,585 items
The digital health collection includes vendors developing software, platforms, sensor & robotic hardware, health data infrastructure, and tech-enabled services in healthcare. The list excludes pureplay pharma/biopharma, sequencing instruments, gene editing, and assistive tech.
Women's Health Tech
482 items
This collection includes companies applying technology to address a spectrum of physical, mental, and social well-being concerns specific to women. Examples include companies in reproductive health, maternal care, fertility tracking, and menopause support.